EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieOpen Access · CC BY-NC 4.0

ConquerFear-HK: A Randomized Controlled Trial of a Metacognition-Based, Manualized Intervention for Fear of Cancer Recurrence among Chinese Cancer Survivors

Danielle Wing Lam Ng, Rachel Ng, Ceci Guo, Julia Chan, Richard Fielding, Julia Wei Chun Tang, Wylie Wai Yee Li, Chi Chung Foo, Ava Kwong, Simon Siu-Man Ng, Dacita Suen, Sara Fung und 5 weitere

Psychotherapy and Psychosomatics · 2025

DOI: 10.1159/000547888 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Psychotherapy and Psychosomatics, 2025. Verfasst von Danielle Wing Lam Ng und 16 weiteren Autor:innen. Beteiligte Einrichtung: Centre for Psycho-Oncological Research and Training, Division of Behavioural Sciences, School of Public Health, The University of Hong Kong, Hong Kon…. Hauptthemen laut MEDLINE: Cancer Survivors, Fear, Neoplasm Recurrence, Local, Metacognition. Die Arbeit nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Fear of cancer recurrence (FCR) is a prominent clinical issue among cancer survivors. This study evaluated the effectiveness of the culturally adapted ConquerFear-HK intervention in reducing FCR among Chinese cancer survivors, compared to standard survivorship care.

Methods

This assessor-masked, two-arm parallel randomized controlled trial, was conducted from June 2021 to February 2024. Cantonese- or Mandarin-speaking Chinese cancer survivors scoring ≥13 on the Fear of Cancer Recurrence Inventory Short Form (FCRI-SF) were randomized to either ConquerFear-HK, focusing on attention training, metacognition modification, acceptance, appropriate monitoring behaviour, and goal setting or active control providing standardized, multidisciplinary survivorship care. Primary outcome was changes in FCR assessed by FCRI at prior randomization, immediately post-intervention (T1), 3 months (T2), and 6 months (T3) post-intervention. Intention-to-treat analyses using linear mixed modelling compared outcome changes across time points. This trial was registered at ClinicalTrials.gov (NCT04568226).

Results

Of the 175/220 (79.5%) participants recruited, 89 were randomized to ConquerFear-HK and 86 to control. Significant greater FCRI reductions were observed in ConquerFear-HK at T1 (mean difference = −10.66; 95% CI:-20.15, −1.16) and T2 (mean difference = −12.00; 95% CI:-21.90, −2.11) vs. the control (g = 0.33–0.36). No significant between-group differences were found at T3.

Conclusion

ConquerFear-HK demonstrates promising short-term (3-month) improvements in FCR among Chinese cancer survivors; however, no sustained benefits were found at 6 months. Possible explanations include the high attrition at 6-month follow-up, a potential early ceiling effect, unconscious therapist bias, or an accelerated adaptation effect in the intervention arm that was achieved later by the control group.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cancer SurvivorsFearNeoplasm Recurrence, LocalMetacognitionCognitive Behavioral TherapyHumansMaleFemaleMiddle AgedAdultChinaAgedEast Asian People

Stichwörter der Autor:innen

Cancer survivorshipCognitive-behavioural psychotherapyFear of cancer recurrenceMetacognition-based interventionRandomized controlled trial

Autor:innen und Institutionen

  • Centre for Psycho-Oncological Research and Training, Division of Behavioural Sciences, School of Public Health, The University of Hong Kong, Hong Kong, Hong Kong, China.
  • HKU Jockey Club Institute of Cancer Care, LKS Faculty of Medicine, The University of Hong Kong, Hong Kong, Hong Kong, China.
  • Department of Surgery, The University of Hong Kong, Hong Kong, Hong Kong, China.
  • Department of Surgery, The Chinese University of Hong Kong, Hong Kong, Hong Kong, China.
  • Department of Surgery, Kwong Wah Hospital, Hong Kong Hospital Authority, Hong Kong, Hong Kong, China.
  • Department of Obstetric and Gynaecology, The University of Hong Kong, Hong Kong, Hong Kong, China.

Zitieren

APA

Ng, D. W. L., Ng, R., Guo, C., Chan, J., Fielding, R., Tang, J. W. C., Li, W. W. Y., Foo, C. C., Kwong, A., Ng, S. S., Suen, D., Fung, S., Chun, O. K., Chan, K. K. L., Chang, A. T. Y., Butow, P., & Lam, W. W. T. (2025). ConquerFear-HK: A Randomized Controlled Trial of a Metacognition-Based, Manualized Intervention for Fear of Cancer Recurrence among Chinese Cancer Survivors. Psychotherapy and Psychosomatics. https://doi.org/10.1159/000547888

Vancouver

Ng DWL, Ng R, Guo C, Chan J, Fielding R, Tang JWC, et al. ConquerFear-HK: A Randomized Controlled Trial of a Metacognition-Based, Manualized Intervention for Fear of Cancer Recurrence among Chinese Cancer Survivors. Psychotherapy and Psychosomatics. 2025. doi:10.1159/000547888

BibTeX
@article{Ng2025,
  author = {Ng, Danielle Wing Lam and Ng, Rachel and Guo, Ceci and Chan, Julia and Fielding, Richard and Tang, Julia Wei Chun and Li, Wylie Wai Yee and Foo, Chi Chung and Kwong, Ava and Ng, Simon Siu-Man and Suen, Dacita and Fung, Sara and Chun, Oi Kwan and Chan, Karen Kar Loen and Chang, Amy Tien Yee and Butow, Phyllis and Lam, Wendy Wing Tak},
  title = {ConquerFear-HK: A Randomized Controlled Trial of a Metacognition-Based, Manualized Intervention for Fear of Cancer Recurrence among Chinese Cancer Survivors},
  journal = {Psychotherapy and Psychosomatics},
  year = {2025},
  doi = {10.1159/000547888}
}
Kostenlos starten →